Staff, Department of Inflammation & Immunity
Professor, Cleveland Clinic Lerner College of Medicine
Email: [email protected]
Location: Cleveland Clinic Main Campus
Dr. Bruggeman no longer maintains an active research laboratory. This page reflects her ongoing education and research activity.
Dr. Bruggeman studies the etiology of chronic kidney disease using a variety of basic and translational methods including cell culture, preclinical models and clinical specimens. Chronic kidney diseases of the glomerulus frequently cause nephrotic syndrome and generally involve injury to the primary epithelial cell of the glomerulus, the podocyte. Her focus is on genetic and environmental causes of nephrotic syndrome, in particular, those associated with viral infection of the podocyte and risk attributed to polymorphisms in the APOL1 gene.
Genetic polymorphisms in the gene for apolipoprotein L1 (APOL1) contribute significant risk for several forms of kidney disease associated with the pathologic changes characterized as focal segmental glomerulosclerosis (FSGS).
Several viral infections such as HIV-1 and SARS-CoV-2 are known triggers for FSGS.
View publications for Leslie Bruggeman, PhD
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Selected recent publications
Huang, C., Z. Wu, K.R. Bartolomeo, J.F. O'Toole, J.R. Sedor, L.A. Bruggeman. Differential regulation of basal and interferon-induced APOL1 gene expression in podocytes. Am J. Physiol. Renal Physiol. 311:F648-F654 (2026).
Wu, Z., T. Azhibekov, C. Huang, J.K. Nguyen, K.R. Bartolomeo, O. Wessely, J.F. O'Toole, J.R. Sedor, L.A. Bruggeman. Impact of APOL1-associated pregnancy complications on kidney disease phenotypes in a HIVAN mouse model. Kidney360 7:1943-1955 (2026).
Bruggeman, L.A. Making a portal for podocyte-parietal cell communication in glomerular injury. Am. J. Physiol. Renal Physiol. 330:F407-F408 (2026).
Azhibekov, T., L.A. Bruggeman. Insidius APOL1 kidney disease: a manifestation of APOL1-associated pregnancy complications on nephron endowment? Cells 14:1373 (2025).
Tassiopoulos, K.K., K. Wu, Z. Wu, E.T. Overton, F.J. Palella, C. Wyatt, R.C. Kalayjian, L.A. Bruggeman. APOL1 genotype and HIV infection: 20 year outcomes for CKD, CVD and hypertension. Kidney Int Reports, 10:855-865 (2025).
Agudelo, J., X. Chen, S.D. Mukherjee, J.K. Nguyen, L.A. Bruggeman, A.W. Miller. Cefazolin shifts the kidney microbiota to promote a lithogenic environment. Nat Commun, 15:10509 (2024).
Nguyen, J.K., Z. Wu, J. Agudelo, L.C. Herlitz, A.W. Miller, L.A. Bruggeman. Local inflammation but not kidney cell infection associated with high APOL1 expression in COVID-associated nephropathy. Kidney360, 4: 175-1762 (2023).
Hong, C., F. Eichinger, M. Atta, M. Estrella, D. Fine, M.J. Ross, C. Wyatt, T.H. Hwang, M. Kretzler, J.R. Sedor, J.F. O’Toole, A.W. Miller, and L.A. Bruggeman. Viral associations with kidney disease diagnosis and altered metatranscriptome by kidney function. Kidney Int. 103:218-222 (2023).
Azhibekov, T., R. Durodoye, A.K. Miller, C.L. Simpson, R.L. Davis, S.M. Williams, L.A. Bruggeman. Fetal high risk APOL1 genotype increases risk for small for gestational age in term infants affected by preeclampsia. Neonatology Apr 14: 1-5 (2023).
Miller, A.K, T. Azhibekov, J. F. O’Toole, J. R. Sedor, S. M. Williams, R.W. Redline, L. A. Bruggeman. Association of preeclampsia with infant APOL1 genotype in African Americans. BMC Med. Genet. 21:110 (2020).
Bruggeman, L.A., Z. Wu, L. Lou, S. M. Madhavan, P. Drawz, D. B. Thomas, L. Barisoni, J. F. O'Toole, J. R. Sedor. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy. PLoS One. 14(10):e0224408 (2019).
Our education and training programs offer hands-on experience at one of the nationʼs top hospitals. Travel, publish in high impact journals and collaborate with investigators to solve real-world biomedical research questions.
Learn MoreDr. Bruggeman and team use sequencing data to identify novel factors that cause kidney diseases of unknown origin.
Drs. Bruggeman, Sedor and O’Toole will investigate the pathogenic mechanisms of chronic kidney disease to develop greater understanding of genetic susceptibility and develop new treatment strategies.
By studying a model of HIV-associated nephropathy, a group of kidney disease researchers and clinicians discovered that in patients with the APOL1 risk gene, the presence of an environmental stressor, like a virus, can trigger cell changes that lead to chronic kidney diseases.